Mesothelioma Cancer Resources Blog

Source: Centers for Disease Control and Prevention The Centers for Disease Control and Prevention (CDC) has recently released a report detailing the numbers of deaths and years of productivity lost among people who died before 65 years-old because of asbestosis. The CDC’s report only looked at asbestosis-related deaths, so these numbers do not take into …

Source: Science Daily Scientists from Ohio State University have announced exciting results from a study they were conducting on the manner in which asbestos fibers interact with human cells and, possibly, cause mesothelioma. For the first time in the history of asbestos science, the scientists have identified a particular mechanism by which crocidolite fibers bind …

Source: Occupational Health & Safety State Assets LLC, a building development company based in Brooklyn, NY was fined by OSHA for 18 alleged violations of a number of different health and safety statutes, including statues regulating the handling of asbestos. Alongside the asbestos violations, OSHA also cited the company for violations of fire and electrical …

Source: BTG Life sciences company BTG has licensed its experimental anti-cancer compound, BGC 945, to Onxy pharmaceuticals, who will further develop and commercialize the compound. BGC 945 is an anti-cancer agent in the class of compounds known as TS inhibitors—compounds which derive their cancer treatment effects from the inhibition of thymidylate synthase (TS), an enzyme …

Source: Lung Cancer A recent issue of the journal Lung Cancer contains an article detailing the results of a study that looked at the efficacy of pemetrexed-based chemotherapy for the treatment of malignant peritoneal mesothelioma. The authors describe their study as the largest one completed that specifically addressed the use of pemetrexed for peritoneal disease. …

Source: New York Times The New York Times is running an article on a recently-released study on cancer recurrence rates conducted by the Weill Cornell Medical College in New York that showed delays in starting treatment led to higher rates of recurrence when compared to those who began therapy right away. The researchers analyzed the …